Yang H, Cheng X, Chen Y, Zeng Z, Wang G
Arch Med Sci Atheroscler Dis. 2024; 9:e1-e15.
PMID: 38434940
PMC: 10905262.
DOI: 10.5114/amsad/177534.
Williams Jr J, Gambaro G, Rodgers A, Asplin J, Bonny O, Costa-Bauza A
Urolithiasis. 2020; 49(1):1-16.
PMID: 33048172
PMC: 7867533.
DOI: 10.1007/s00240-020-01217-3.
Perrier E, Armstrong L, Bottin J, Clark W, Dolci A, Guelinckx I
Eur J Nutr. 2020; 60(3):1167-1180.
PMID: 32632658
PMC: 7987589.
DOI: 10.1007/s00394-020-02296-z.
Peacock M
Calcif Tissue Int. 2020; 108(1):3-15.
PMID: 32266417
DOI: 10.1007/s00223-020-00686-3.
Seeger H, Kaelin A, Ferraro P, Weber D, Jaeger P, Ambuehl P
BMC Nephrol. 2017; 18(1):349.
PMID: 29202723
PMC: 5715611.
DOI: 10.1186/s12882-017-0755-7.
Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stones.
Hall J, Yerramilli M, Obare E, Li J, Yerramilli M, Jewell D
PLoS One. 2017; 12(4):e0174854.
PMID: 28384169
PMC: 5383095.
DOI: 10.1371/journal.pone.0174854.
Stress-stones-stress-recurrent stones: a self-propagating cycle? Difficulties in solving this dichotomy.
Arzoz-Fabregas M, Roca-Antonio J, Ibarz-Servio L, Jappie-Mahomed D, Rodgers A
Urolithiasis. 2017; 45(6):515-524.
PMID: 28324150
DOI: 10.1007/s00240-017-0970-5.
Physicochemical mechanisms of stone formation.
Rodgers A
Urolithiasis. 2016; 45(1):27-32.
PMID: 27928586
DOI: 10.1007/s00240-016-0942-1.
Recent advances in managing and understanding nephrolithiasis/nephrocalcinosis.
Gambaro G, Trinchieri A
F1000Res. 2016; 5.
PMID: 27134735
PMC: 4837977.
DOI: 10.12688/f1000research.7126.1.
Methods for diagnosing the risk factors of stone formation.
Robertson W
Arab J Urol. 2015; 10(3):250-7.
PMID: 26558033
PMC: 4442929.
DOI: 10.1016/j.aju.2012.03.006.
SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration.
Ware E, Riehle E, Smith J, Zhao W, Turner S, Kardia S
PLoS One. 2015; 10(7):e0128593.
PMID: 26167684
PMC: 4500555.
DOI: 10.1371/journal.pone.0128593.
A biological stone from a medieval cemetery in Poland.
Gladykowska-Rzeczycka J, Nowakowski D
PLoS One. 2014; 9(9):e109096.
PMID: 25275551
PMC: 4183561.
DOI: 10.1371/journal.pone.0109096.
A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.
Tiselius H
Urol Res. 2011; 39(4):231-43.
PMID: 21246193
DOI: 10.1007/s00240-010-0349-3.
Comparison of Metabolic Risk Factors in Urolithiasis Patients according to Family History.
Park C, Ha Y, Kim Y, Yun S, Lee S, Kim W
Korean J Urol. 2010; 51(1):50-3.
PMID: 20414411
PMC: 2855461.
DOI: 10.4111/kju.2010.51.1.50.
Clinical risk index in urolithiasis.
Marickar Y, Salim A
Urol Res. 2009; 37(5):283-7.
PMID: 19609518
DOI: 10.1007/s00240-009-0208-2.
Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.
Monico C, Weinstein A, Jiang Z, Rohlinger A, Cogal A, Bjornson B
Am J Kidney Dis. 2008; 52(6):1096-103.
PMID: 18951670
PMC: 2710965.
DOI: 10.1053/j.ajkd.2008.07.041.
Mineralogy and chemistry of urinary stones: patients from North Jordan.
Abboud I
Environ Geochem Health. 2007; 30(5):445-63.
PMID: 18064405
DOI: 10.1007/s10653-007-9128-7.
Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors.
Safarinejad M
Urol Res. 2007; 35(2):73-82.
PMID: 17361397
DOI: 10.1007/s00240-007-0084-6.
Effect of dietary control of urinary uric acid excretion in calcium oxalate stone formers and non-stone-forming controls.
Pais Jr V, Holmes R, Assimos D
J Endourol. 2007; 21(2):232-5.
PMID: 17338626
PMC: 2705619.
DOI: 10.1089/end.2007.2218.
Gastrointestinal oxalic acid absorption in calcium-treated rats.
Morozumi M, Hossain R, Yamakawa K, Hokama S, Nishijima S, Oshiro Y
Urol Res. 2006; 34(3):168-72.
PMID: 16705467
DOI: 10.1007/s00240-006-0035-7.